Lifecore Biomedical

Chaska, Minnesotalifecore.com1expert edge

NASDAQ-traded sterile injectable CDMO with 40+ years of expertise in fill-finish, formulation development, and premium hyaluronic acid production. Serves biopharmaceutical clients across multiple therapeutic modalities with facilities in Minnesota and Europe.

Why interesting to a deal team

Board director via 22NW cooperation agreement (Paul H. Johnson) provides governance insight and syndication pathway; public company demonstrates CDMO sector valuation and exit precedent for sterile injectable platform.

Experts connected to this company

Paul H. JohnsonBoard director added via 22NW cooperation agreement

Paul H. Johnson

Executive Chairman

Tjoapack

AdvisorSan Antonio

Executive Chairman of Tjoapack and 30-year CDMO operator who sold DPT/Renaissance to Mylan for $950M — brings both operating and PE-diligence lenses to topicals/injectables manufacturing.

Sources

Structured dataPrimary
lifecore.com
Page titleOther
finance.yahoo.com/quote/LFCR

Strongest evidenceStructured data2 public sourcesHow the grades work